机译:优化遵守欧洲冠心病患者预防准则的成本效益:Euroaspire IV调查结果
Univ Ghent Dept Publ Hlth Ghent Belgium;
Univ Ghent Dept Publ Hlth Ghent Belgium;
Univ Ghent Dept Publ Hlth Ghent Belgium;
Univ Ghent Dept Publ Hlth Ghent Belgium;
Karolinska Inst Dept Med Solna Cardiol Unit Stockholm Sweden;
Imperial Coll London Int Ctr Circulatory Hlth Natl Heart &
Lung Inst London England;
Univ Lille Inst Pasteur Lille Villeneuve Dascq France;
Charles Univ Prague Med Fac 1 Ctr Cardiovasc Prevent Prague Czech Republic;
Charles Univ Prague Med Fac 1 Ctr Cardiovasc Prevent Prague Czech Republic;
Univ Ghent Dept Internal Med Ghent Belgium;
Shupyks Natl Med Acad Postgrad Educ Dept Cardiol Kiev Ukraine;
Univ Latvia Pouts Stradins Clin Univ Hosp Riga Latvia;
Natl Heart Hosp Dept Cardiol Sofia Bulgaria;
Karolinska Inst Dept Med Solna Cardiol Unit Stockholm Sweden;
Vilnius Univ Vilnius Univ Hosp Santaros Klin Heart &
Vasc Med Clin Cardiovasc Dis Vilnius;
Clin Internal Med Intermed Nish Serbia;
Minist Healthcare Russian Federat Natl Res Ctr Prevent Med Moscow Russia;
Jagiellonian Univ Med Coll Fac Hlth Sci Dept Epidemiol &
Populat Studies Krakow Poland;
Natl Res Ctr Prevent Med Fed Hlth Ctr Moscow Russia;
Univ Zagreb Sch Med Univ Hosp Ctr Zagreb Zagreb Croatia;
Skane Univ Hosp Dept Heart Failure &
Valve Dis Lund Sweden;
Univ Ghent Dept Publ Hlth Ghent Belgium;
Secondary prevention; Guidelines; Cost-effectiveness; Coronary heart disease; EUROASPIRE;
机译:优化遵守欧洲冠心病患者预防准则的成本效益:Euroaspire IV调查结果
机译:24个欧洲国家冠心病患者慢性肾病及其决定因素的患病率:欧洲心脏病学会Euroaspire IV调查的见解
机译:欧洲冠心病患者的吸烟停止。 Euroaspire IV调查结果:欧洲心脏病学会的注册处
机译:冠心病患者的差分高血压控制:通过干预减少事件的欧洲级预防措施(欧洲宣传)II研究
机译:在实施HEARTFELT(心力衰竭有效性和领导力团队)干预措施前后,都要遵守实践准则和心力衰竭患者的预后。
机译:冠心病患者的心力衰竭:患病率特征和指南实施–德国EuroAspire IV研究组的结果
机译:24个欧洲国家的慢性肾脏疾病患病率及其在冠心病患者中的决定因素:欧洲心脏病学会EUROaspIRE IV调查的见解